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ABSTRACT
Objectives: The aim of this study was to analyze the psychomet-
ric and diagnostic properties of the Clock Drawing Test (CDT),
scored according to the Babins, Rouleau, and Cahn scoring sys-
tems, for Mild Cognitive Impairment (MCI) and Alzheimer’s disease
(AD) screening, and develop corresponding cutoff scores.
Additionally, we assessed the construct validity of the CDT
through exploratory and confirmatory factor analysis.
Methods: We developed a cross-sectional study of ambulatory
MCI and AD patients, divided in two clinical groups (450MCI and
250 mild AD patients) and a normal control group (N¼ 400). All
participants were assessed with the CDT, Mini-Mental State
Examination (MMSE) and Montreal Cognitive Assessment (MoCA)
for convergent validity.
Results: The selected scoring systems presented adequate validity
and reliability values. The proposed cutoff scores showed 60 to
65% sensitivity and 58 to 62% specificity to identify MCI patients.
The corresponding values for AD were 84 to 90% sensitivity and
76 to 78% specificity. Exploratory and confirmatory factor analysis
revealed that the Babins scoring system had good construct valid-
ity and allowed us to propose a three-factor model for this system.
Conclusions: Our results confirmed the complexity of the CDT
and support it as a cognitive screening instrument particularly
sensitive to AD. The use of the CDT with MCI patients should be
interpreted with more caution due to the lower sensitivity and
specificity for milder forms of cognitive impairment.
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The Clock Drawing Test (CDT) was created to assess visuospatial functions related to
the parietal lobes (Battersby, Bender, Polack, & Kahn, 1956). Forthcoming studies
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suggested the involvement of other cognitive functions, namely symbolic and grapho-
motor representation, auditory linguistic abilities, executive functions (organization,
planning, and parallel processing), hemiattention, semantic memory, and conceptual
abilities (Cosentino, Jefferson, Chute, Kaplan, & Libon, 2004; Freedman et al., 1994;
Libon, Malamut, Swenson, Sands, & Cloud, 1996; Mendez, Ala, & Underwood, 1992;
Rouleau, Salmon, Butters, Kennedy, & McGuire, 1992; Shulman, 2000; Strauss, Sherman,
& Spreen, 2006).
One of the most common uses of the CDT in the last 20 years has been the differ-
entiation of the cognitively normal from groups with cognitive impairment. This
remains a topic of international interest, reflected in the numerous studies continu-
ously published about the CDT capacity to detect Mild Cognitive Impairment (MCI)
and multiple forms of cognitive impairment and dementia (e.g. Aprahamian,
Radanovic, Nunes, Ladeira, & Forlenza, 2014; Cahn-Weiner et al., 2003; Duro, Tabuas-
Pereira, Freitas, Santiago, Botelho, & Santana, 2018; Lowery et al., 2003; Mazancova,
Nikolai, Stepankova, Kopecek, & Bezdicek, 2017; Parsey & Schmitter-Edgecombe, 2011;
Ricci et al., 2016; Rubinova et al., 2014; Tan, Herrmann, Mainland, & Shulman, 2015;
Terwindt, Hubers, Giltay, van der Mast, & van Duijn, 2016; Viscogliosi, Chiriac,
Andreozzi, & Ettorre, 2016; Yoo & Lee, 2016; Vyhnalek et al., 2017).
MCI is a transitional entity between normal aging and Alzheimer’s disease (AD),
which makes the discrimination between normal aging and pathology a frequently dif-
ficult challenge (Petersen et al., 1999; Petersen et al., 2009; Albert et al., 2011). It is
considered both an incipient stage of dementia and a situation of risk for the develop-
ment of the disease, though this progression does not always occur. About 10–15%
per year and 80% over 6 years of these patients develop some type of dementia
(Petersen et al., 2009) and some predictors of conversion from MCI to AD have been
identified, including neuropsychological data, neuroimaging and biomarkers, alone or
in combination. Objectively, MCI has been clinically defined as a self or informant-
reported cognitive complaint and an objective cognitive impairment that surpasses
what is expectable in subjects with a certain age and education, while functional activ-
ities of daily living remain relatively intact (Petersen et al., 1999; Albert et al., 2011).
The aim of this study was to conduct a validation study of the Babins, Slater,
Whitehead, and Chertkow (2008), Cahn et al. (1996) and Rouleau et al. (1992) scoring
systems for MCI and AD screening. We conducted an analysis of the psychometric
properties and diagnostic accuracy of the selected scoring systems, and established
optimal cut-off scores for the detection of MCI and AD, as compared to healthy con-
trol subjects. Additionally, we analyzed the CDT construct validity through exploratory
and confirmatory factor analysis.
Methods
Participants and procedures
We selected a convenience sample of MCI and mild AD patients previously referred
for comprehensive neuropsychological assessment at the Neuropsychology Laboratory
of a Portuguese tertiary center. MCI patients included in this study were of the amnes-
tic type and the diagnosis was made in accordance with the criteria defined by
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Petersen et al. (2001) and more recently the framework for MCI due to AD, proposed
by NIA-AA criteria (Albert et al., 2011). Diagnostic investigation included a standard
clinical evaluation, an extensive cognitive and staging assessment, laboratory tests,
imaging studies (CT or MRI and SPECT), CSF analysis, APOE genotyping and eventually
PiB–PET. At baseline, a neurologist completed a medical history with the patient and
the caregiver and conducted a general physical, neurological and psychiatric examin-
ation, as well as a comprehensive diagnostic battery, which included: (1) cognitive
instruments as the Mini-Mental State Examination (MMSE; Folstein, Folstein, &
McHugh, 1975), Portuguese version (Guerreiro, Silva, Botelho, Leit~ao, & Garcia, 1994);
the Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005), Portuguese ver-
sion (Sim~oes et al., 2008); the Alzheimer Disease Assessment Scale-Cognitive (ADAS-
Cog; Mohs, Rosen, & Davis, 1983; Rosen, Mohs, & Davis, 1984), Portuguese version
(Guerreiro, Fonseca, & Barreto, 2003); and a comprehensive neuropsychological battery
with normative data for the Portuguese population (the Lisbon Battery for Assessment
of Dementia, Portuguese acronym BLAD; Guerreiro, 1998) (data not shown); (2) stand-
ard staging scales which provided objective information about individual performance
in various domains, including the Clinical Dementia Rating scale (CDR; Berg, 1988),
Portuguese version (Garret et al., 2008) for global staging; the Disability Assessment
for Dementia (DAD; Gelinas, Gauthier, McIntyre, & Gauthier, 1999), Portuguese version
(Leit~ao, 2008) for evaluation of functional status; the Neuropsychiatric Inventory (NPI;
Cummings, 1997), Portuguese version (Leit~ao & Nina, 2003) to characterize the psycho-
pathological profile; and the Geriatric Depression Scale (GDS-30; Yesavage et al., 1983),
Portuguese version (Barreto, Leuschner, Santos, & Sobral, 2008) to exclude
major depression.
All available information (baseline cognitive tests, staging scales, clinical laboratory,
and imaging studies) was used to reach a consensus diagnosis. The inclusion criteria
for amnestic MCI were those proposed by Petersen et al. (2001) and were operational-
ized as follows: (1) subjective complaints of memory decline (reported by the subject
or an informant); (2) objective memory impairment (considered when scores on stand-
ard Wechsler memory tests were >1.5 SDs below age/education adjusted norms) with
or without deficits in other cognitive domains; (3) normal global cognition suggested
by normal scores in the MMSE and MoCA using the Portuguese cut off scores
(Guerreiro et al., 1994; Freitas, Sim~oes, Alves, & Santana, 2011); (4) largely normal daily
life activities, evaluated with a functional scale-DAD; (5) absence of dementia, indi-
cated by a CDR rating of 0.5. As exclusion criteria for enrolment, we considered a
MMSE score <19; a significant underlying medical or neurological illness revealed by
laboratory tests or imaging; a relevant psychiatric disease, including major depression,
suggested in the medical interview and confirmed by the GDS; CT or MRI demonstra-
tion of significant vascular burden (Roman et al., 1993).
As for the mild AD clinical group, diagnosis was established according to the
Diagnostic and Statistical Manual of Mental Disorders-fourth edition criteria for demen-
tia (DSM-IV-TR; APA, 1994) and specific criteria for AD (McKhann et al., 1984, 2011).
These patients should have had: (1) objective evidence of dementia by cognitive test-
ing (using the MMSE, MoCA, and the ADAS-COG scores and qualitative evaluation, i.e.
impairment of memory plus another domain); (2) a MMSE score 15; (3) a global CDR
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rating from 0.5 to 1, confirming the cognitive profile of dementia and loss
of autonomy.
The control group was composed by healthy volunteer subjects living in the com-
munity. In brief, they were recruited according to the following criteria: (a) informed
consent; (b) Portuguese as mother language and formal education received in
Portuguese schools; (c) normal score (according to age and education) on two cogni-
tive screening instruments validated for the Portuguese population, the MMSE and the
MoCA; (d) preserved independence and functionality; (e) no severe depressive symp-
tomatology (GDS-30 20); (f) no history of psychiatric, neurologic or other diseases
with a negative impact in cognition; (g) no medication with a negative impact in cog-
nition; (h) no significant motor, visual or auditory deficits with a possible negative
impact in cognition; (i) no present or past history of alcoholism or drug abuse. For full
description of recruitment methods, please consult Santana, Duro, Freitas, Alves, and
Sim~oes (2013).
MCI and AD patients included in this study were recruited after the diagnosis was
established; the evaluation session was conducted as part of their ambulatory follow
up and consisted of the CDT, MMSE, and MoCA (by order of application). The clock
drawings from all participants were later scored by the same neuropsychologist
according to the Babins et al. (2008), Rouleau et al. (1992), and Cahn et al. (1996) scor-
ing systems (by this order).
An informed consent was obtained from all participants after the research aims and
procedures were fully explained by a member of the research team. The present
research complied with the ethical guidelines on human experimentation stated on
the Declaration of Helsinki and was approved by the Portuguese Foundation for
Science and Technology and by the Faculty of Medicine of the University of Coimbra
Scientific Committee.
Clock Drawing Test scoring systems
The 18-points Babins scoring system assesses in detail several clock components: clock
face (2 points); center (2 points); type and organization of numbers (6 points); clock
hands (6 points); and global gestalt (2 points) (Babins et al., 2008). The Rouleau et al.
(1992) scoring system is a 10 point quantitative system that encompasses the three
major clock components: clock face (2 points), numbers (4 points), and hands (4
points). The Cahn scoring system combines the Rouleau quantitative score with a
qualitative analysis of the eight types of error most commonly found in clock drawing
as described by Freedman: (1) stimulus-bound response (placement of minute hand
towards the number “10” instead of “2”; (2) conceptual deficit (multiple errors which
reflect a difficulty in assessing specific characteristics of the clock related with the
numbers or the hands); (3) perseveration (numbers beyond 12 or repetitions of the
same number); (4) left hemispace neglect (all numbers placed in one side of the clock
face, usually the right hemispace); (5) planning deficit (errors in the placement of 12,
3, 6, and 9); (6) nonspecific spatial error (errors in the placement of numbers with no
specific pattern referred in the previous errors); (7) numbers outside the clock; (8)
numbers counter clockwise (Cahn et al., 1996; Freedman et al., 1994).
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All study participants were assessed by two certified and experienced neuropsychol-
ogists (DD and SF). The clock drawing instructions given to the participants were the
following: “I want you to draw a round clock, place all the numbers, and set the time
for ten past eleven.” The words “hands” and “minutes” were preferably avoided as
they constituted hints for the execution process. All clock drawings from both the clin-
ical and control groups were scored by an experienced neuropsychologist (DD); for
the purpose of analyzing interrater reliability, a subgroup of randomly selected clock
drawings from MCI patients was scored by a neurologist with no previous experience
in neuropsychology (except for training related with the CDT and the selected scor-
ing methods).
Statistical analysis
Statistical analyses were performed using the Statistical Package for the Social
Sciences (SPSS, version 19.0) and a p value of .05 was considered statistically signifi-
cant. Descriptive statistics were used for sample’s characterization and two sample t-
test as well as independence chi-square (v2) test allowed the group comparisons. The
convergent validity was determined using Pearson’s correlation coefficients between
the CDT scoring systems, MoCA, and MMSE scores. Interrater reliability was determined
by Pearson correlations between CDT scores of two independent raters; we included
Cohen’s kappa as an additional measure of interrater reliability. The group differences
were examined with independent samples t-test, analysis of variance (ANOVA) (with
Bonferroni post hoc test) and analysis of covariance (ANCOVA).
The diagnostic accuracy of the three CDT scoring systems for the prediction of a
clinical diagnosis of MCI and AD was assessed through receiver operating characteris-
tics (ROC) curve analysis. In this analysis, the area under the curve (AUC) can vary
between 0.5 and 1 and a larger AUC indicates better diagnostic accuracy. The optimal
cutoff points for each scoring system that yielded the highest Youden’s index were
selected, with the highest value indicating maximization of sensitivity and specificity.
For the analysis of the predictive value of this test we calculated, for each cutoff point,
the sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV), and classification accuracy.
Exploratory factor analysis (EFA) (principal axis factor analysis with varimax rotation)
was used in order to determine the factorial structure of the CDT scoring systems. The
proposed models, when applicable, were analyzed through confirmatory factor ana-
lysis (CFA), conducted with Analysis of Moment Structures (AMOS) version 19.0
(Arbuckle, 2010). The following guidelines were used concerning model fit criteria and
acceptable fit interpretation (Bentler & Bonett, 1980; Brown, 2006; Cochran, 1952;
Cramer, 1998; Hu & Bentler, 1999; Macmann & Barnett, 1994; Maruyama, 1998;
Schumacker & Lomax, 2004): Goodness-of-Fit Index (GFI) and Adjusted Goodness-of-Fit
Index (AGFI) values greater than 0.90 and close to 0.95 reflected a good fit; the
Comparative Fit Index (CFI) with values closer to 1.0 implied good model fit and had
the advantage of reflecting the degree of fit relatively well at all sample sizes; the
Incremental Fit Index (IFI) attempted to correct the possibility of the chosen model
being improved (closer to 1.0) by merely adding parameters; Root Mean Square Error
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of Approximation (RMSEA) values closer to 0.06 or very close to 0 suggested good
model fit; finally, a v2 test lower value represented a better adjustment.
Results
The final sample included 1100 subjects, divided by the three groups as follows:
450MCI, 250 AD, and 400 healthy controls. The mean age of the participants was
69.47 (±8.89) years, and 6.69 (±4.14) years of education. 63.5% of the subjects were
female. There were no differences between the groups regarding gender distribution
(v2=3.033, p=.220). As for age, the control group was slightly younger than the MCI
group and they were both younger than the AD group [F(2,1097)=87.340, p<.001].
There were also differences regarding education: the MCI group had more years of for-
mal education than the AD group [F(2,1182)=6.054, p<.01]. The complete characteriza-
tion of the study sample is described in Table 1.
Group differences
There were significant differences between the groups in all cognitive measures,
including the three CDT scoring systems (see Table 1). In order to assess the existence
of group differences once the effects of age and education were controlled, we per-
formed an ANCOVA with these variables as covariates. The results showed that the
variable diagnosis maintained a significant effect (Table 2).
Psychometric properties
The CDT scoring systems had values of internal consistency ranging from .439 to .901;
Cronbach’s alpha values were significantly higher for the Babins system. Cronbach’s
alpha values according to each group and each scoring system are presented in
Table 3.
The Babins scoring system presented high correlations with the Rouleau (r=.964,
p< .001) and Cahn (r=.948, p< .001) scoring systems. There were also moderate sig-
nificant correlations with the MMSE and the MoCA, which can be considered indicative
of convergent validity. The lowest correlations were found between the CDT scoring
systems and the MMSE (Table 3). Additionally, we correlated the CDT scores with the
Table 2. Analysis of covariance of Clock Drawing Test scores as a function of diagnosis.
F df Sig. Partial eta2 Mean difference 95% C.I.
Babins 177.930 2 <.001 .246 CNT vs MCI: 1.450 ± .264 .816–2.084
CNT vs AD: 5.934 ± .323 5.160–6.707
MCI vs AD: 4.484 ± .299 3.768–5.200
Rouleau 170.632 2 <.001 .238 CNT vs MCI: .718 ± .140 .381–1.054
CNT vs AD: 3.077 ± .171 2.666–3.488
MCI vs AD: 2.359 ± .159 1.979–2.740
Cahn 192.874 2 <.001 .261 CNT vs MCI: 1.352 ± .186 .916–1.799
CNT vs AD: 4.425 ± .228 3.879–4.971
MCI vs AD: 3.072 ± .211 2.568–3.577
Note: N¼ 1100. F testes the effect of Diagnosis. Results for mean difference are presented as corrected mean differ-
ence ± standard error. Covariates: age and education.
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MoCA subscores according to cognitive domains. We found significant correlations
between all CDT scores and the six cognitive domains. Specifically, the Babins total
score correlated with memory (r=.379, p< .001), visuospatial ability (r=.813, p< .001),
executive functions (r=.575, p< .001), attention/working memory (r=.507, p< .001), lan-
guage (r=.461, p< .001), and orientation (r=.451, p< .001). Similarly, the Rouleau score
correlated with memory (r=.365, p< .001), visuospatial ability (r=.814, p< .001), execu-
tive functions (r=.551, p< .001), attention/working memory (r=.500, p< .001), language
(r=.446, p< .001), and orientation (r=.452, p< .001). Finally, the Cahn score correlated
with memory (r=.402, p< .001), visuospatial ability (r=.814, p< .001), executive func-
tions (r=.554, p< .001), attention/working memory (r=.506, p< .001), language (r=.440,
p< .001), and orientation (r=.455, p< .001).
Inter-rater reliability of the CDT was assessed in a subgroup of 70 randomly
selected MCI subjects that were scored by two independent raters. We found high sig-
nificant correlations between total scores of both raters in the Babins (r=.897, p<.001),
Rouleau (r=.895, p<.001), and Cahn scoring systems (total score: r=.871, p<.001; quali-
tative errors: r=.691, p<.001). Cohen’s j was run as an alternative measure to deter-
mine if there was agreement between the two independent raters. The results showed
that there was a fair agreement between the two raters using the Babins system
(j=.289, p<.001), the Rouleau system (j=.346, p<.001), and the Cahn system
(j=.237, p<.001).
Cut-off points and diagnostic accuracy
Receiver operating characteristics (ROC) curve analysis was performed to determine
the CDT diagnostic accuracy to discriminate MCI and AD patients from healthy control
subjects. The Babins system had an AUC of .638 for MCI (p<.001; S.E.=.019; 95%
C.I.=.601, .675) and .886 for AD detection (p<.001; S.E.=.013; 95% C.I.=.861, .911). The
optimal cutoff scores for detection of MCI and AD were calculated based on Youden’s
index. A cutoff of 15 points showed 61% diagnostic accuracy for MCI (sensitivity
Table 3. Psychometric properties of the Clock Drawing Test.
Total
sample (N¼ 1100) MCI (N¼ 450) AD (N¼ 250) CNT (N¼ 400)
Reliability
(Cronbach’s alpha)
Babins .901 .878 .833 .879
Rouleau .560 .439 .442 .476




Rouleau/Cahn .978 .979 .953 .972
Rouleau/Babins .964 .949 .941 .953
Cahn/Babins .948 .931 .906 .932
Rouleau/MMSE .606 .366 .380 .420
Rouleau/MoCA .711 .564 .584 .577
Cahn/MMSE .606 .366 .328 .422
Cahn/MoCA .723 .536 .549 .574
Babins/MMSE .608 .355 .368 .457
Babins/MoCA .725 .571 .583 .608
MMSE/MoCA .817 .647 .677 .614
MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease; CNT, control group; MMSE, Mini-Mental State Examination;
MoCA, Montreal Cognitive Assessment.
All correlation values are significant at p<.001 level.
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=60%; specificity =62%; PPV =61; NPV =61); for AD detection, a cutoff of 12 points
had 81% accuracy (sensitivity =84%; specificity =78%; PPV =79; NPV =83).
The Rouleau system had an AUC of .635 for MCI (p<.001; S.E.=.019; 95% C.I.=.597,
.673) and .874 for AD detection (p<.001; S.E.=.013; 95% C.I.=.848, .901). A cutoff of 9
points showed 61% diagnostic accuracy for MCI (sensitivity =64%; specificity =58%;
PPV =60; NPV =62); for AD detection, a cutoff of 7 points had 81% accuracy (sensitiv-
ity =84%; specificity =78%; PPV =79; NPV =83).
The Cahn system had an AUC of .657 for MCI (p<.001; S.E.=.019; 95% C.I.=.620,
.694) and .897 for AD detection (p<.001; S.E.=.012; 95% C.I.=.873, .921). A cutoff of 8
points showed 63% diagnostic accuracy for MCI (sensitivity =65%; specificity =61%;
PPV =63; NPV =64); for AD detection, a cutoff of 6 points had 83% accuracy (sensitiv-
ity =90%; specificity =76%; PPV =79; NPV =88).
For comparison purposes a similar analysis was performed for the MMSE and
MoCA. The MMSE presented an AUC of .679 (p<.001) with 48% sensitivity and 78%
specificity for MCI detection (63% diagnostic accuracy), and an AUC of .969 (p<.001)
with 85% sensitivity and 97% specificity for AD (91% diagnostic accuracy). The MoCA
revealed an AUC of .779 (p<.001) with 71% sensitivity and 70% specificity for MCI
detection (71% diagnostic accuracy), and an AUC of .983 (p<.001) with 95% sensitivity
and 91% specificity for AD (93% diagnostic accuracy).
Exploratory factor analysis (EFA)
Principal axis factor analysis with varimax rotation was used in order to determine the
factorial structure of the three CDT scoring systems. For the Rouleau and Cahn scoring
systems, only one factor could be extracted; the corresponding factors explained 57
and 60% of the variability of results for Rouleau and Cahn respectively. As for the
Babins scoring system, after rotation we found three factors that explained 64% of
variability: the first factor (time-setting) accounted for 36.2% of the variance; the




Two recognizable hands .940 .92
Hands are joined .938 .91
Hour hand towards correct number .895 .87
Center .845 .74
Minute hand towards correct number .803 .74
Size difference of hands is respected .762 .65
Gestalt .578 .425 .422 .69
Arrows are drawn .488 .30
Numbers all the same .783 .62
Numbers inside circle .766 .59
Numbers clockwise and correct sequence .692 .61
No missing or added numbers .577 .55
Spacing equal (3, 6, 9, and 12) .688 .51
Clock face .649 .43
Spacing equal (1, 2, 4, 5, 7, 8, 10, and 11) .629 .51
Eigenvalues 5.431 2.359 1.851
% of variance 36.21 15.73 12.34
N¼ 1100. Loadings <.40 are omitted.
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second factor (display characteristics) explained 15.7% of the variance of results; finally,
a third factor (planning) explained 12.3% of the variance of results. Table 4 displays
the items and factor loadings for the rotated factors, with loadings less than .40 omit-
ted to improve clarity.
Confirmatory factor analysis (CFA)
As a final measure of construct validity of the CDT, we applied CFA to the Babins scor-
ing system. Our goal was to determine the possibility of creating alternative scoring
methods based on the 18 points and explore their capacity to detect different types of
cognitive impairment (instead of a single total score). As starting point for CFA, we used
the factorial structure previously obtained through EFA. We analyzed different models
according to several adjustment indexes. The first model (Model 1) included all items
grouped according to the results of EFA in three factors. After following several modifi-
cation indexes proposed by the system, we defined the final three factor model (Model
2): the items composing each factor kept the original organization except “gestalt” that
was transposed to the second factor (display characteristics). The adjustment indexes
are presented in Table 5; Model 2a represents the optimal model and resulted from the
establishment of intercorrelations between the items (as suggested by the software).
As a final analysis, we were interested in determining if the participants’ scores dif-
fered according to each factor. We performed an ANOVA with Bonferroni correction
for multiple comparisons and found statistically significant differences between the
three groups in all factors, following the same pattern: CNT>MCI>AD. However, the
analysis of effect size showed that the differences between CNT and MCI patients
were medium for display characteristics and small for time-setting. Results are pre-
sented in detail in Table 6.
Table 5. Confirmatory factor analysis: adjustment indexes.
Model v2 d.f. p GFI AGFI CFI IFI RMSEA
Model 1 1347.5 87 <.001 .839 .778 .896 .896 .115
Model 2 1173.1 87 <.001 .859 .805 .910 .911 .107
Model 2a 289.1 71 <.001 .966 .942 .982 .982 .053
N¼ 1100. Bold values enlighten the CFA model with best adjustment indexes.
v2, Chi-square; d.f., degrees of freedom; GFI, Goodness-of-Fit Index; AGFI, Adjusted Goodness-of-Fit Index; CFI,
Comparative Fit Index; IFI, Incremental Fit Index; RMSEA, Root Mean Squared Error of Approximation.
Table 6. Group differences according to Babins factors based on confirmatory factor analysis.
Factor CNT MCI AD Mean difference Sig. 95% CI Effect size (d)
Time-setting 5.54 (2.862) 5.01 (3.008) 1.78 (2.553) CNT>MCI: 0.527 .022 0.06–1.00 0.180
CNT>AD: 3.764 .000 3.21–4.32 1.387
MCI>AD: 3.237 .000 2.70–3.78 1.158
Display characteristics 5.43 (1.064) 4.88 (1.353) 3.34 (1.684) CNT>MCI: 0.545 .000 0.32–0.77 0.452
CNT>AD: 2.081 .000 1.82–2.34 1.484
MCI>AD: 1.536 .000 1.28–1.79 1.008
Planning 2.91 (0.866) 2.26 (0.837) 1.72 (0.641) CNT>MCI: 0.648 .000 0.51–0.78 0.763
CNT>AD: 1.188 .000 1.03–1.34 1.562
MCI>AD: 0.540 .000 0.39–0.69 0.724
N¼ 1100. Results are presented as mean (standard deviation).
CFA, confirmatory factor analysis; CNT, control group; MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease; CI,
confidence interval.
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Discussion
The main purpose of this study was to validate the CDT as a cognitive screening
measure for MCI and AD. Specifically, we conducted a thorough validation study of
three scoring systems (Babins, Rouleau, and Cahn) and determined optimal cutoff
scores for the identification of MCI and AD. The results confirmed that the CDT is a
valid and reliable measure for the screening of MCI and AD patients, and can be used
as a cognitive screening tool when more complex and time-consuming instruments
are not available. This assumption is also supported by the moderate to high correla-
tions with the MMSE and the MoCA, including correlations with the MoCA cognitive
domains, suggesting convergent validity. The CDT has a clear advantage relative to
the most common cognitive screening tools: it is easy to administer and score, well
accepted by patients from all age ranges, and less time-consuming. We selected quan-
titative and qualitative scoring systems with the same administration method and
they all have been described in the literature as having good psychometric properties
and good sensitivity and specificity values for MCI and AD. Also, the CDT, unlike the
MMSE or MoCA, does not require any overt spoken response nor does the CDT rely
much on episodic memory and temporal orientation. Moreover, while the MoCA and
MMSE contain visuospatial construction items, particularly the MoCA, which includes a
clock drawing, a detailed empirically-based method for analyzing errors on the visuo-
spatial construction items on these measures does not exist.
The analysis of interrater reliability, particularly the high correlations obtained
between the ratings of an experienced neuropsychologist versus a neurologist with no
specific experience in neuropsychology supported the broad use of the CDT in clinical
practice (specifically with these scoring systems). Our results are in line with other
international studies that have suggested that the CDT has high interrater reliability
regardless of the scoring system used (e.g. Shulman, 2000; Aprahamian, Martinelli,
Neri, & Yassuda, 2009; Pinto & Peters, 2009; Duro et al., 2015; Jorgensen, Kristensen,
Waldemar, & Vogel, 2014; Mazancova et al., 2017; Vyhnalek et al., 2017). This is a very
important aspect as it is crucial to guarantee that the patient will receive the same
score regardless of the health professional that administers the test.
ROC curve analysis of the selected scoring systems showed that all have a signifi-
cantly higher diagnostic accuracy for AD detection (81–83%) than for MCI (58–61%).
Several studies have addressed the CDT’s poor diagnostic accuracy for the identifica-
tion of MCI subjects (e.g. Pinto & Peters, 2009; Ehreke, Luppa, Konig, & Riedel-Heller,
2010), while others revealed more optimistic results. Parsey and Schmitter-Edgecombe
(2011) used a modified version of the Rouleau system and showed that it had higher
sensitivity for AD and MCI when they included the analysis of qualitative errors in the
final score: they reported 39% sensitivity/88% specificity to distinguish MCI from con-
trols and 58% sensitivity/100% specificity to distinguish AD from MCI. In the original
study by Babins et al. (2008), the proposed scoring system revealed 76% specificity
and 90% sensitivity in differentiating AD patients from cognitively normal subjects and
78% sensitivity in the identification of the MCI subgroup of subjects who later devel-
oped dementia. Placement of the hands proved to be the most discriminative task
among the four analyzed groups, even between MCI subgroups (non progressors ver-
sus progressors), and could therefore be used as an indicator of future cognitive
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decline (Babins et al., 2008). Our results with this scoring system are closer to the ones
described in a German population-based longitudinal study: the authors found 60%
sensitivity and 70% specificity for the Babins system, for the screening of MCI (Ehreke
et al., 2010). Other recent studies continued to present similar values concerning MCI
and AD detection (e.g. Mazancova et al., 2017; Reiner, Eichler, Hertel, Hoffman, &
Thyrian, 2017; Vyhnalek et al., 2017) regardless of the scoring systems used. The lower
sensitivity for MCI can be explained by several factors. MCI is a heterogeneous group:
there can be single domain or multidomain cognitive impairment and this fact can
justify the difficulty of tests such as the CDT to have better diagnostic accuracy in
large samples. Also, a significant percentage of MCI patients remain stable over time,
not developing AD or other forms of dementia. As we were able to confirm, even
other cognitive screening tests such as the MMSE or the MoCA, despite having specific
items for different cognitive domains, present sensitivity and specificity values for MCI
closer to the CDT (although slightly higher for the MoCA). In future research it will be
interesting to compare MCI patients with single and multidomain deficits longitudin-
ally and analyze if there are differences between these groups regarding the develop-
ment of cognitive deficits (including the performance on the CDT).
Despite having comparable diagnostic accuracy, the Babins system has revealed
better psychometric properties than the Rouleau and the Cahn systems in the
Portuguese population (e.g. Duro et al., 2015, Duro et al., 2018). In line with this fact,
we decided to further explore the validity of these scoring systems regarding their
construct validity. While the Rouleau and Cahn scoring systems resulted in a single
factor solution, the Babins systems revealed a three factor solution, a fact that
prompted us to conduct CFA. The practical implications of this CFA study allowed us
to propose a three factor factorial structure for the Babins scoring system: Time-set-
ting, Display Characteristics and Planning. Such levels of confirmatory model fit offer
plausibility and trustworthiness of the hypothesized three factor structure (Model 2a, 3
factors), especially given the fact that the competing factor models, also tested, speci-
fying alternative dimensionalities, presented evidently lesser levels of fit. The results of
the CFA suggest possible future studies where we can consider correlating these find-
ings with other neuropsychological tests or domains, or event neuroimaging data.
Also, it showed us that different clock components may be related with similar cogni-
tive processes. As future research, it will be interesting to confirm if we can establish a
correlation with specific regions of interest or cognitive functions, eventually develop-
ing alternative scoring methods within the existent ones in order to increase the diag-
nostic accuracy for milder forms of cognitive impairment.
This study makes a valuable contribution by allowing a more precise and accurate
use of the CDT in clinical practice, for several reasons: (1) we used thoroughly studied
MCI and AD patients, having excluded patients with uncertain diagnoses; (2) we
included the participants’ first cognitive assessment data for analysis (after the estab-
lishment of the diagnosis by our clinical team)—our purpose was to determine the
CDT’s usefulness as a cognitive screening measure at an early stage; (3) we used a
rigorous methodology—all participants were assessed by experienced neuropsycholo-
gists and all clock drawings were scored by a single neuropsychologist (DD), thus min-
imizing interpersonal bias; (4) we presented cutoff scores for MCI and AD (and not a
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single cutoff score for global cognitive impairment); (5) we presented original con-
struct validity data. This is the first known study of CFA with the CDT, particularly the
Babins scoring system. It is important to acknowledge the lack of other CFA studies
which would allow a more specific comparative analysis of our results.
However, this study has some limitations. The clinical groups and the control group
do not match according to age and education, a consequence of the use of conveni-
ence samples from our memory clinic. There is a higher concentration of younger con-
trol subjects (although with age ranges equivalent to the clinical groups); MCI patients
were also younger than AD patients, which can be explained by the natural course of
the disease (MCI state usually precedes a diagnosis of AD or other forms of dementia).
Also, we excluded all participants with significant depressive symptomatology, which
limits the applicability of our data with this particular segment of the population.
As closing remarks, this study is part of a more global project with the main goal
of validating the CDT as a cognitive screening instrument for use not only in special-
ized centers but in primary care where neuropsychological assessment is not available.
We believe we produced important data regarding the utility of CDT as a cognitive
screening instrument for amnestic MCI and AD. As shown by our results, the CDT
(regardless of the scoring system used) presented a fair diagnostic accuracy for MCI;
the same scoring systems revealed good to excellent diagnostic accuracy for mild AD.
In face of such results, we can recommend the CDT as a complementary screening
instrument for AD, while the use of this instrument with MCI patients must be made
as part of a more complex assessment protocol. Once again, our data allow us to con-
clude that the CDT should never replace a comprehensive neuropsychological assess-
ment but it can produce valuable data for referral purposes.
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